HIC2 and central nervous system cancer: As shown in Figure 1A, the promoter of HIC2 was highly methylated at three CpG sites, including cg13558199 (p < 0.05), cg20944928 (p < 0.05), and cg22869804 (p < 0.05), in glioma samples.